These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34206855)

  • 21. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.
    Lehnart SE; Mongillo M; Bellinger A; Lindegger N; Chen BX; Hsueh W; Reiken S; Wronska A; Drew LJ; Ward CW; Lederer WJ; Kass RS; Morley G; Marks AR
    J Clin Invest; 2008 Jun; 118(6):2230-45. PubMed ID: 18483626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.
    Itzhaki I; Maizels L; Huber I; Gepstein A; Arbel G; Caspi O; Miller L; Belhassen B; Nof E; Glikson M; Gepstein L
    J Am Coll Cardiol; 2012 Sep; 60(11):990-1000. PubMed ID: 22749309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular, Subcellular, and Arrhythmogenic Mechanisms in Genetic RyR2 Disease.
    Fowler ED; Zissimopoulos S
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.
    Nakamura Y; Yamamoto T; Kobayashi S; Tamitani M; Hamada Y; Fukui G; Xu X; Nishimura S; Kato T; Uchinoumi H; Oda T; Okuda S; Yano M
    JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.
    Novak A; Lorber A; Itskovitz-Eldor J; Binah O
    Rambam Maimonides Med J; 2012 Jul; 3(3):e0015. PubMed ID: 23908839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.
    Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK
    Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model.
    Kobayashi S; Yano M; Uchinoumi H; Suetomi T; Susa T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Yamamoto T; Matsuzaki M
    Circ J; 2010 Nov; 74(12):2579-84. PubMed ID: 20944434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
    Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes.
    Acimovic I; Refaat MM; Moreau A; Salykin A; Reiken S; Sleiman Y; Souidi M; Přibyl J; Kajava AV; Richard S; Lu JT; Chevalier P; Skládal P; Dvořak P; Rotrekl V; Marks AR; Scheinman MM; Lacampagne A; Meli AC
    J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30413023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.
    Xiao Z; Guo W; Sun B; Hunt DJ; Wei J; Liu Y; Wang Y; Wang R; Jones PP; Back TG; Chen SRW
    J Biol Chem; 2016 Nov; 291(47):24528-24537. PubMed ID: 27733687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Changes in the Cardiac RyR2 With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
    Dulhunty AF
    Front Physiol; 2022; 13():830367. PubMed ID: 35222090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts.
    Tateishi H; Yano M; Mochizuki M; Suetomi T; Ono M; Xu X; Uchinoumi H; Okuda S; Oda T; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Cardiovasc Res; 2009 Feb; 81(3):536-45. PubMed ID: 18996969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca
    Ottesen AH; Carlson CR; Eken OS; Sadredini M; Myhre PL; Shen X; Dalhus B; Laver DR; Lunde PK; Kurola J; Lunde M; Hoff JE; Godang K; Sjaastad I; Pettilä V; Stridsberg M; Lehnart SE; Edwards AG; Lunde IG; Omland T; Stokke MK; Christensen G; Røsjø H; Louch WE
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e007045. PubMed ID: 30943765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
    Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT
    J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
    Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein expression profiles in murine ventricles modeling catecholaminergic polymorphic ventricular tachycardia: effects of genotype and sex.
    Saadeh K; Achercouk Z; Fazmin IT; Nantha Kumar N; Salvage SC; Edling CE; Huang CL; Jeevaratnam K
    Ann N Y Acad Sci; 2020 Oct; 1478(1):63-74. PubMed ID: 32713021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca
    Sun B; Wei J; Zhong X; Guo W; Yao J; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Chen SRW
    J Biol Chem; 2018 Aug; 293(35):13650-13661. PubMed ID: 29986885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.